Strides Shasun Gets 3 Observations From USFDA For Bangalore Plant


Strides Shasun on Monday announced that the USFDA has issued 3 observations after inspecting its formulations facility in Bangalore.

"The formulations facility in Bangalore was recently inspected by the US FDA. The company has been issued a Form 483 with 3 observations," said StridesShasun in its BSE filing on Monday.

The company said that none of these observations are related to data integrity and quality control and the company will address the observations comprehensively.

StridesShasun was trading at Rs 896.15, down by Rs 21.60 or 3.35, as at 11.50, on Monday, on the BSE. The stock had hit an intraday low of Rs 877.

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔
Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: